Novavax (NVAX) Treasury Shares (2010 - 2026)

Novavax's Treasury Shares history runs 17 years deep, the most recent figure standing at $112.3 million for Q1 2026.

• On a quarterly basis, Treasury Shares rose 10.18% year-over-year to $112.3 million in Q1 2026; TTM through Mar 2026 was $112.3 million, a 10.18% increase from a year earlier, with the FY2025 full-year figure at $103.0 million, up 7.48% from the prior year.
• Treasury Shares climbed to $112.3 million in Q1 2026 per NVAX's latest filing, from $103.0 million in the prior quarter.
• Across five years, Treasury Shares topped out at $7.1 million in Q1 2025 and bottomed at $149843.0 in Q4 2025.
• The 5-year median for Treasury Shares is $1.4 million (2022), against an average of $2.4 million.
• Across the five-year window, Treasury Shares jumped 93.22% in 2022 and gained 1.77% in 2023, its largest moves.
• Year by year, Treasury Shares stood at $90.7 million in 2022, then grew by 1.77% to $92.3 million in 2023, then grew by 3.89% to $95.9 million in 2024, then gained by 7.48% to $103.0 million in 2025, then climbed by 9.03% to $112.3 million in 2026.
• Per Business Quant, the three latest NVAX Treasury Shares figures stand at $112.3 million (Q1 2026), $103.0 million (Q4 2025), and $102.7 million (Q3 2025).